|2005N-0354||Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing|
|FDA Comment Number :||EC133|
|Submitter :||Mr. David Sanders||Date & Time:||12/07/2005 06:12:26|
|Organization :||Mr. David Sanders|
|Category :||Individual Consumer|
| Please bar the unethical and misleading advertising of psychiatric drugs on TV, the web and in print.
This is expecially vital for those psychiatric drug ads that claim to help correct a 'chemical imbalance.' It turns out there is no scientific evidence that such a chemical imbalance exists, let alone that any drug helps 'correct' it.
It opens up some very big companies to charges of false advertising and worse. It is a very bad thing to have the FDA condoning.
Furthermore, the suicide and homicide and other side effects do not get adequate play in these ads for obvious reasons, and 'black box' labeling is not being properly portrayed in the advertising.
Cigarette companies have been relegated to a low profile in advertising their products which cause people harm. The same should go for these drugs.